Annual Revenue
$25.18 M
+$22.63 M+886.80%
31 December 2023
Summary:
Capricor Therapeutics annual revenue is currently $25.18 million, with the most recent change of +$22.63 million (+886.80%) on 31 December 2023. During the last 3 years, it has risen by +$24.93 million (+10180.97%). CAPR annual revenue is now at all-time high.CAPR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$2.26 M
-$1.71 M-43.05%
30 September 2024
Summary:
Capricor Therapeutics quarterly revenue is currently $2.26 million, with the most recent change of -$1.71 million (-43.05%) on 30 September 2024. Over the past year, it has dropped by -$9.83 million (-81.29%). CAPR quarterly revenue is now -81.29% below its all-time high of $12.09 million, reached on 31 December 2023.CAPR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$23.23 M
-$3.92 M-14.45%
30 September 2024
Summary:
Capricor Therapeutics TTM revenue is currently $23.23 million, with the most recent change of -$3.92 million (-14.45%) on 30 September 2024. Over the past year, it has dropped by -$1.95 million (-7.75%). CAPR TTM revenue is now -14.45% below its all-time high of $27.15 million, reached on 30 June 2024.CAPR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CAPR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -81.3% | -7.8% |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | +2405.3% | +918.3% | +2211.0% |
CAPR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -81.3% | +135.6% | -14.4% | +1359.4% |
| 5 y | 5 years | at high | >+9999.0% | -81.3% | >+9999.0% | -14.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -81.3% | +1256.8% | -14.4% |
Capricor Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.26 M(-43.1%) | $23.23 M(-14.5%) |
| June 2024 | - | $3.97 M(-19.1%) | $27.15 M(+0.2%) |
| Mar 2024 | - | $4.91 M(-59.4%) | $27.10 M(+7.6%) |
| Dec 2023 | $25.18 M(+886.8%) | $12.09 M(+95.4%) | $25.18 M(+79.2%) |
| Sept 2023 | - | $6.19 M(+57.9%) | $14.05 M(+48.6%) |
| June 2023 | - | $3.92 M(+31.2%) | $9.46 M(+70.7%) |
| Mar 2023 | - | $2.99 M(+211.1%) | $5.54 M(+117.1%) |
| Dec 2022 | $2.55 M(+941.9%) | $959.90 K(-39.7%) | $2.55 M(+60.3%) |
| Sept 2022 | - | $1.59 M(+679.8%) | $1.59 M(+398.0%) |
| Dec 2021 | $244.90 K(-21.1%) | - | - |
| June 2021 | - | $204.10 K(+400.2%) | $319.60 K(+93.2%) |
| Mar 2021 | - | $40.80 K(-29.4%) | $165.40 K(-46.7%) |
| Dec 2020 | $310.30 K(-69.1%) | $57.80 K(+242.0%) | $310.30 K(-34.6%) |
| Sept 2020 | - | $16.90 K(-66.1%) | $474.60 K(-20.9%) |
| June 2020 | - | $49.90 K(-73.1%) | $599.80 K(-37.5%) |
| Mar 2020 | - | $185.70 K(-16.4%) | $960.30 K(-4.5%) |
| Dec 2019 | $1.00 M(-39.9%) | $222.10 K(+56.3%) | $1.01 M(-29.8%) |
| Sept 2019 | - | $142.10 K(-65.4%) | $1.43 M(-5.1%) |
| June 2019 | - | $410.40 K(+78.0%) | $1.51 M(+0.4%) |
| Mar 2019 | - | $230.50 K(-64.4%) | $1.50 M(-10.1%) |
| Dec 2018 | $1.67 M(-37.3%) | $648.10 K(+195.7%) | $1.67 M(+11.5%) |
| Sept 2018 | - | $219.20 K(-45.7%) | $1.50 M(-5.9%) |
| June 2018 | - | $404.00 K(+1.0%) | $1.59 M(-27.1%) |
| Mar 2018 | - | $400.10 K(-15.9%) | $2.19 M(-18.0%) |
| Dec 2017 | $2.67 M | $475.80 K(+51.9%) | $2.67 M(-7.2%) |
| Sept 2017 | - | $313.30 K(-68.6%) | $2.87 M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $996.50 K(+13.1%) | $3.24 M(+2.7%) |
| Mar 2017 | - | $880.80 K(+28.8%) | $3.16 M(-1.0%) |
| Dec 2016 | $3.19 M(-15.5%) | $683.60 K(0.0%) | $3.19 M(-6.7%) |
| Sept 2016 | - | $683.60 K(-25.0%) | $3.42 M(-6.3%) |
| June 2016 | - | $911.50 K(0.0%) | $3.65 M(0.0%) |
| Mar 2016 | - | $911.50 K(0.0%) | $3.65 M(-3.4%) |
| Dec 2015 | $3.78 M(-9.4%) | $911.50 K(0.0%) | $3.78 M(-3.3%) |
| Sept 2015 | - | $911.50 K(0.0%) | $3.91 M(-3.2%) |
| June 2015 | - | $911.50 K(-12.5%) | $4.04 M(-3.1%) |
| Mar 2015 | - | $1.04 M(0.0%) | $4.17 M(0.0%) |
| Dec 2014 | $4.17 M(+207.6%) | $1.04 M(0.0%) | $4.17 M(+33.3%) |
| Sept 2014 | - | $1.04 M(0.0%) | $3.13 M(+50.0%) |
| June 2014 | - | $1.04 M(0.0%) | $2.08 M(+100.0%) |
| Mar 2014 | - | $1.04 M(-632.8%) | $1.04 M(>+9900.0%) |
| Dec 2012 | - | -$195.50 K(-200.0%) | $0.00(-100.0%) |
| Mar 2012 | - | $195.50 K(0.0%) | $1.55 M(+14.4%) |
| Dec 2011 | $1.35 M(+1235.8%) | $195.50 K(-76.0%) | $1.35 M(+16.9%) |
| Sept 2011 | - | $813.00 K(+135.0%) | $1.16 M(+235.0%) |
| June 2011 | - | $346.00 K(+241.2%) | $346.00 K(+241.2%) |
| Dec 2007 | $101.40 K(-73.4%) | - | - |
| Sept 2007 | - | $101.40 K(+4509.1%) | $101.40 K(+4509.1%) |
| Dec 2006 | $380.80 K(>+9900.0%) | - | - |
| Dec 2003 | $2200.00(-80.9%) | - | - |
| Sept 2003 | - | $2200.00(>+9900.0%) | $2200.00(-80.9%) |
| Dec 2002 | $11.50 K | - | - |
| June 2002 | - | $0.00(-100.0%) | $11.50 K(0.0%) |
| Mar 2002 | - | $11.50 K | $11.50 K |
FAQ
- What is Capricor Therapeutics annual revenue?
- What is the all time high annual revenue for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly revenue year-on-year change?
- What is Capricor Therapeutics TTM revenue?
- What is the all time high TTM revenue for Capricor Therapeutics?
- What is Capricor Therapeutics TTM revenue year-on-year change?
What is Capricor Therapeutics annual revenue?
The current annual revenue of CAPR is $25.18 M
What is the all time high annual revenue for Capricor Therapeutics?
Capricor Therapeutics all-time high annual revenue is $25.18 M
What is Capricor Therapeutics quarterly revenue?
The current quarterly revenue of CAPR is $2.26 M
What is the all time high quarterly revenue for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly revenue is $12.09 M
What is Capricor Therapeutics quarterly revenue year-on-year change?
Over the past year, CAPR quarterly revenue has changed by -$9.83 M (-81.29%)
What is Capricor Therapeutics TTM revenue?
The current TTM revenue of CAPR is $23.23 M
What is the all time high TTM revenue for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM revenue is $27.15 M
What is Capricor Therapeutics TTM revenue year-on-year change?
Over the past year, CAPR TTM revenue has changed by -$1.95 M (-7.75%)